Androgen News and Research

RSS

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Oncotarget Volume 11, Issue 12 reported outside its natural niche, the cultured prostate cancer stem cells lost their tumor-inducing capability and stem cell marker expression after approximately 8 transfers at a 1:3 split ratio.

27 Mar 2020

Highly focused radiation may slow disease progression in men with oligometastatic prostate cancer

Highly focused, intense doses of radiation called stereotactic ablative radiation (SABR) may slow progression of disease in a subset of men with hormone-sensitive prostate cancers that have spread to a few separate sites in the body, according to results of a phase II clinical trial of the therapy.

26 Mar 2020

Intense and targeted radiotherapy could slow progression of certain prostate cancers

Targeted and strong doses of stereotactic ablative radiation (SABR) radiotherapy could slow progression in prostate cancer.

26 Mar 2020

Exercise works for prostate cancer sufferers starting treatment

A James Cook University researcher says scientists have found that exercise can be beneficial to patients as they begin treatment for prostate cancer.

11 Mar 2020

NCCN publishes recommendations for assessing quality improvements in cancer care

The National Comprehensive Cancer Network has published a curated list of high-impact measures for assessing quality improvements in cancer care.

10 Mar 2020

Antidepressant shows promise in helping men with recurrent prostate cancer

An antidepressant in use for decades, repurposed to fight prostate cancer, shows promise in helping patients whose disease has returned following surgery or radiation, a pilot study at USC shows.

4 Mar 2020

Moffitt research may provide a path toward improved multi-drug adaptive therapies

Personalized cancer treatments have greatly improved the lives of patients; however, many eventually develop resistance to these targeted drugs.

13 Feb 2020

Statin use alone or with metformin may increase survival in high-risk prostate cancer patients

Among high-risk prostate cancer patients - those with high PSA and Gleason scores of 8 or more - many will develop a difficult-to-treat disease.

10 Feb 2020

Study evaluates the impact of prostate cancer treatment decisions

A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.

27 Jan 2020

Scientists discover new drug target for prostate cancer in the non-coding genome

Scientists at Princess Margaret Cancer Centre have identified the drivers of a crucial gene involved in prostate cancer, revealing new targets for drug design.

23 Jan 2020

Researchers uncover genetic anomaly linked with poor response to common asthma treatment

A new Cleveland Clinic study has uncovered a genetic anomaly associated with poor response to a common asthma treatment.

13 Jan 2020

Administering enzalutamide results in significant increase in PSMA density on tumor surface

When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewhat remote, rather idealistic genius sitting alone in their room or laboratory and somehow discovering the most amazing things without every having contact with the 'normal' world.

9 Jan 2020

Short-term exercise could help to reduce side-effects of prostate hormone therapy

A prescription of short-term exercise for patients with advanced prostate cancer could help to reduce the side-effects of hormone therapy, according to new research from the University of East Anglia.

9 Dec 2019

Roswell Park-led scientists identify new defense mechanism against prostate cancer

A research team led by a scientist at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer. Writing in the journal Nature Communications, the team documents their findings from preclinical studies showing that overexpression of the LRIG1 protein inhibits prostate cancer development, while reducing naturally occurring LRIG1 promotes prostate tumor development.

3 Dec 2019

Daughters of women with PCOS five times more likely to develop the syndrome in adulthood

Daughters of women with polycystic ovarian syndrome are five times more likely to be diagnosed with PCOS as adults, and the generational transmission is driven by high androgen levels during pregnancy, researchers at Karolinska Institutet in Sweden report.

2 Dec 2019

Androgen News and Research

Research characterizes iPS87 cell line as cancer-inducing, stem cell-like cell line

Highly focused radiation may slow disease progression in men with oligometastatic prostate cancer

Intense and targeted radiotherapy could slow progression of certain prostate cancers

Exercise works for prostate cancer sufferers starting treatment

NCCN publishes recommendations for assessing quality improvements in cancer care

Antidepressant shows promise in helping men with recurrent prostate cancer

Moffitt research may provide a path toward improved multi-drug adaptive therapies

Statin use alone or with metformin may increase survival in high-risk prostate cancer patients

Study evaluates the impact of prostate cancer treatment decisions

Scientists discover new drug target for prostate cancer in the non-coding genome

Researchers uncover genetic anomaly linked with poor response to common asthma treatment

Administering enzalutamide results in significant increase in PSMA density on tumor surface

Short-term exercise could help to reduce side-effects of prostate hormone therapy

Roswell Park-led scientists identify new defense mechanism against prostate cancer

Daughters of women with PCOS five times more likely to develop the syndrome in adulthood

Prostate cancer 'super responders' could live for two years or more on immunotherapy

Scientists find driver for more deadly prostate cancer

UCLA prostate cancer program receives $8.7 million grant from NCI

Research: Alternative pathway to production of male hormones is present during human fetal development

Lab-grown, testosterone-producing cells could help treat hypogonadism

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News